Joe Raedle/Getty Photographs Information
Edwards Lifesciences (NYSE:EW) and Medtronic (NYSE:MDT) trended increased within the premarket on Wednesday after their rival coronary heart valve maker Boston Scientific (NYSE:BSX) determined to discontinue international gross sales of its ACURATE neo2 and ACURATE Prime aortic
